Dysport, approved by the FDA in 2009, has been widely used in other countries for years. And in the U.S., it is quickly catching up to it’s competitor in popularity. In fact, a report published in the Los Angeles Times (Botox face-off: Choice of toxin may matter (at least for crow’s feet), June 21, 2011) says people prefer Dysport over Botox for the treatment of crows feet wrinkles.
According to the report, researchers conducted a “randomized, double-blind” study in which subjects were treated with Dysport on one side of the face and Botox on the other. Researchers found that after 30 days “two-thirds of the patients said they preferred the Dysport side of their face.”
To learn more about Dypsort, please click on the following link: Treatment with Botox and Dysport